Evidence map›Paper›PMID 24462704›Full record

ArticleCellular signalling2014

Decreased expression and DNA methylation levels of GATAD1 in preeclamptic placentas.

Xiaoling Ma, Jinping Li, Brian Brost, Wenjun Cheng, Shi-Wen Jiang

Abstract read
In one paragraph

Article in Cellular signalling, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Xiaoling MaDepartment of Gynecology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Department of Biomedical Science, Mercer University School of Medicine, Savannah Campus, GA, USA.
Jinping LiDepartment of Biomedical Science, Mercer University School of Medicine, Savannah Campus, GA, USA; Department of Obstetrics and Gynecology, Mayo Clinic and Mayo Medical College, Rochester, MN, USA.
Brian BrostDepartment of Obstetrics and Gynecology, Mayo Clinic and Mayo Medical College, Rochester, MN, USA.
Wenjun ChengDepartment of Gynecology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Electronic address: wenjuncheng117@gmail.com.
Shi-Wen JiangDepartment of Biomedical Science, Mercer University School of Medicine, Savannah Campus, GA, USA; Department of Obstetrics and Gynecology, Mayo Clinic and Mayo Medical College, Rochester, MN, USA; Department of Obstetrics and Gynecology, Memorial Health Hospital, Savannah, GA, USA. Electronic address: jiang_s@mercer.edu.
Mercer University · USJiangsu Province Hospital · CNMayo Clinic in Arizona · US

Funding

Transcription Enhancer Factor Control of Placental GenesR01HD041577 · NICHD · MERCER UNIVERSITY MACON · PI JIANG, SHI-WEN · 2003 to 2007
$1.3M
NICHD NIH HHS R01 HD041577NICHD NIH HHS R01 HD41577
6 · The paper itself

Abstract

Expression of syncytin-1, or the human endogenous retroviral family W member 1 (HERVWE1) in human placental trophoblasts is regulated by DNA methylation. Increased DNA methylation and decreased expression of syncytin-1 have been observed in preeclamptic placentas. The syncytin-1-mediated fusogenic as well as non-fusogenic activities, e.g., cell cycle promotion, anti-apoptosis, and immune suppression, are implicated in the pathogenic changes in preeclamptic placentas. It is noteworthy that in a close vicinity to syncytin-1 there are two genes, peroxisome biogenesis factor 1 (PEX1) and GATA zinc finger domain containing 1 (GATAD1), as well as multiple CpG islands around these genes. In this study we determined if these adjacent genes might, like syncytin-1, subject to epigenetic regulation in preeclamptic placentas. Data from quantitative real-time PCR and Western blotting indicated that while PEX1 expression remained stable, GATAD1 expression was significantly decreased in the third-trimester placentas associated with preeclampsia than those associated with normal pregnancy. Immunohistochemistry detected high GATAD1 expression in trophoblast linage, and confirmed its reduced levels in preeclamptic placentas. However, COBRA and bisulfate sequencing detected decreased DNA methylation in levels in the 3 [prime] region of GATAD1 gene in preeclamptic placentas. The positive correlation between 3 [prime] methylation and GATAD1 expression was confirmed by treatment of choriocarcinoma JAR cells with DNMT inhibitor. These data pointed to a potential role of GATAD1 for the syncytium deficiency often associated with preeclamptic placentas. The sharp contrast of the methylation alterations for the closely positioned GATAD1 and HERVWE1 may provide a useful model for studying the accurate control of DNA methylation as well as their positive and negative impact on gene expression in placental trophoblasts.

Indexed as

DNA MethylationGene Expression RegulationATPases Associated with Diverse Cellular ActivitiesCell Line, TumorCpG IslandsEye ProteinsFemaleGene Products, envHumansMembrane ProteinsPlacentaPre-EclampsiaPregnancyPregnancy ProteinsPregnancy Trimester, ThirdSequence Analysis, DNAATPases Associated with Diverse Cellular ActivitiesEye ProteinsGATAD1 protein, humanGene Products, envMembrane ProteinsPEX1 protein, humanPregnancy ProteinssyncytinDNA methylationGATAD1HERVWE1Placental trophoblastPreeclampsiaSyncytin-1

Identifiers

PMID24462704
PMCPMC4644424
OpenAlexW1981726775

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.